Analyst Price Targets — CLBT
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 12, 2026 1:39 pm | Eric Martinuzzi | Lake Street | $21.00 | $13.86 | TheFly | Cellebrite price target lowered to $21 from $23 at Lake Street |
| February 12, 2026 1:38 pm | — | UBS | $23.00 | $13.85 | TheFly | Cellebrite price target lowered to $23 from $25 at TD Cowen |
| February 12, 2026 12:18 pm | — | Needham | $18.00 | $14.26 | TheFly | Cellebrite price target lowered to $18 from $24 at Needham |
| October 23, 2024 9:09 am | Tomer Zilberman | Bank of America Securities | $20.00 | $18.11 | TheFly | Cellebrite price target raised to $20 from $17 at BofA |
| September 25, 2024 8:53 am | Jeff Van Rhee | Craig-Hallum | $23.00 | $16.87 | TheFly | Cellebrite price target raised to $23 from $20 at Craig-Hallum |
| August 16, 2024 8:50 am | Eric Martinuzzi | Loop Capital Markets | $17.00 | $16.15 | StreetInsider | Cellebrite (CLBT) PT Raised to $17 at Lake Street Capital Markets |
| August 16, 2024 6:59 am | Tomer Zilberman | Bank of America Securities | $17.00 | $14.96 | TheFly | Cellebrite price target raised to $17 from $13 at BofA |
| April 1, 2024 8:41 am | Jeff Van Rhee | Craig-Hallum | $16.00 | $11.08 | TheFly | Cellebrite price target raised to $16 from $14 at Craig-Hallum |
Latest News for CLBT
/PRNewswire/ -- Cellebrite DI Ltd. (Nasdaq: CLBT), líder mundial en soluciones de inteligencia e investigación digital basadas en IA para los sectores público
/PRNewswire/ -- Cellebrite DI Ltd. (Nasdaq: CLBT), ein weltweit führender Anbieter von KI-gestützten Lösungen für digitale Ermittlungen und
Hundreds gathered to recognize the best and brightest in digital investigations TYSONS CORNER, Va. and PETAH TIKVA, Israel, April 15, 2026 /PRNewswire/ -- Cellebrite DI Ltd.
Shares of Cellebrite DI Ltd. (NASDAQ: CLBT - Get Free Report) reached a new 52-week low during trading on Friday. The stock traded as low as $11.30 and last traded at $11.6640, with a volume of 947531 shares changing hands. The stock had previously closed at $12.41. Analyst Upgrades and Downgrades CLBT has been the
Paychex (NASDAQ: PAYX - Get Free Report) and Cellebrite DI (NASDAQ: CLBT - Get Free Report) are both computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, profitability, earnings and dividends. Risk and Volatility Paychex has a beta
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for CLBT.
U.S. House Trading
No House trades found for CLBT.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.